Wellkind, the Patient App
VMS BioMarketing
Contact Person:
Abigail Mallon, Chief Client Solutions Officer
abigail.mallon@vmsbiomarketing.com
When it comes to healthcare apps, patients are looking for more. In fact, 92% of consumers say that improving the patient experience should be the top goal when deploying digital health tools. VMS BioMarketing is launching Wellkind, an innovative modality for digital engagement, to meet this unaddressed need. Wellkind revolutionizes what healthcare apps are able to accomplish by doing more through automation and leveraging human resources where they are needed most. The app empowers patients by helping them navigate the uncertainty of their treatment and supports better outcomes by providing the information and motivation needed to drive sustained behavior change.
As a one-stop-shop, Wellkind offers two-way connectivity to a nurse, progress monitoring, visibility into the patient’s medication journey, educational content, motivational reminders, and timely nudges. And through data that’s self-reported by patients within the app, functionality can be personalized to specific needs.
Wellkind is designed to be dynamic, evolving as patients progress through their journey and highly synchronized with the broader patient support program since both the nurse and Wellkind are operating from the same technology platform. What stands out about Wellkind is that it is easily accessible and, unlike most digital tools that require a patient to proactively find it, a VMS nurse introduces Wellkind to patients on the first call.
VMS Biomarketing anticipates 2023 results will include 25K+ unique patients using Wellkind as part of their daily therapy management and 10%+ increase in efficiency for clients using Wellkind and nurse support (vs. nurse support alone).
